DE2149750A1 - Erythromycin-Derivate - Google Patents

Erythromycin-Derivate

Info

Publication number
DE2149750A1
DE2149750A1 DE19712149750 DE2149750A DE2149750A1 DE 2149750 A1 DE2149750 A1 DE 2149750A1 DE 19712149750 DE19712149750 DE 19712149750 DE 2149750 A DE2149750 A DE 2149750A DE 2149750 A1 DE2149750 A1 DE 2149750A1
Authority
DE
Germany
Prior art keywords
oxide
hydroxy
positions
erythromycin
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19712149750
Other languages
German (de)
English (en)
Inventor
Paul Kurath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of DE2149750A1 publication Critical patent/DE2149750A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE19712149750 1970-10-06 1971-10-05 Erythromycin-Derivate Pending DE2149750A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7863370A 1970-10-06 1970-10-06

Publications (1)

Publication Number Publication Date
DE2149750A1 true DE2149750A1 (de) 1972-04-13

Family

ID=22145293

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712149750 Pending DE2149750A1 (de) 1970-10-06 1971-10-05 Erythromycin-Derivate

Country Status (7)

Country Link
US (1) US3674773A (enExample)
AU (1) AU456132B2 (enExample)
CA (1) CA955592A (enExample)
DE (1) DE2149750A1 (enExample)
FR (1) FR2110246B1 (enExample)
GB (1) GB1323502A (enExample)
ZA (1) ZA716325B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915956A (en) * 1973-07-09 1975-10-28 Schering Corp Reduction products of everninomicins and methods for their manufacture
US3928387A (en) * 1974-02-04 1975-12-23 Hoffmann La Roche Antibiotic 1745A/X and methods for the production thereof
US4152424A (en) * 1975-07-23 1979-05-01 Hoffmann-La Roche Inc. Antibiotic 1745A/X and methods for the production thereof
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
IT1195299B (it) * 1981-11-27 1988-10-12 Pierrel Spa Procedimento chimico di sintesi per la preparazione di antibiotici macrolidici
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
JPS6187625A (ja) * 1984-10-05 1986-05-06 Satoshi Omura 消化管収縮運動促進剤
US5552533A (en) * 1994-09-14 1996-09-03 Alliedsignal Inc. Preparation of (8S)-8-fluoroerythromycins with N-F fluorinating agents
WO1998023629A1 (fr) * 1996-11-26 1998-06-04 Chugai Seiyaku Kabushiki Kaisha Composes de macrolides comportant une chaine a 13 elements, medicament les contenant et leur procede de preparation
JP4596591B2 (ja) * 2000-03-09 2010-12-08 塩野義製薬株式会社 ８ａ−オキサホモエリスロマイシン誘導体、製造方法、合成中間体および医薬組成物
US20030184085A1 (en) * 2002-02-27 2003-10-02 Thompson Bernard Lee Dual material threading for pipe adapter
FR2995605B1 (fr) * 2012-09-18 2014-09-19 Sanofi Sa Derives de macrolides, leur preparation et leur application therapeutique.

Also Published As

Publication number Publication date
GB1323502A (en) 1973-07-18
AU3375271A (en) 1973-03-29
FR2110246A1 (enExample) 1972-06-02
CA955592A (en) 1974-10-01
US3674773A (en) 1972-07-04
FR2110246B1 (enExample) 1975-08-01
AU456132B2 (en) 1974-12-12
ZA716325B (en) 1972-05-31

Similar Documents

Publication Publication Date Title
DE3120460C2 (enExample)
DE3010544A1 (de) 1h-pyrrolo eckige klammer auf 2,1-c eckige klammer zu eckige klammer auf 1,4 eckige klammer zu benzodiazepin- 2-acrylsaeureamid-verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2630392A1 (de) Dimere anhydrovincaalkaloide und verfahren zu ihrer herstellung
DE2149750A1 (de) Erythromycin-Derivate
DE3219380C2 (de) Desmethoxy-anthracyclinglycoside, Verfahren zu deren Herstellung sowie pharmazeutische Mittel, die diese enthalten
DE3881576T2 (de) Anthracyclinderivate und ihre Verwendung.
DE1935967C3 (de) Naphthacenderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE2831579C3 (de) Tetrahydropyranylether von Daunomycin und Adriamycin, Verfahren zu ihrer Herstellung, sowie diese Verbindungen enthaltende pharmazeutische Zubereitungen
EP0270992A2 (de) Zytostatisch wirksame Anthracyclinderivate
DE2849696A1 (de) Verfahren zur herstellung des antibiotikums c-15003 p-3
DE2537375A1 (de) 9,3'',4''-triacylester des antibiotikums sf-837 m tief 1 sowie verfahren zur herstellung derselben
DE3877658T2 (de) 4'-deshydroxyepipodophyllotoxinglucoside und ihre verwendung.
DE2517293C2 (de) Neue Cardenolid-β-Glykoside, ihre Herstellung und Verwendung
DE3308196A1 (de) Verfahren zur herstellung von 6'-alkyl-spectinomycin sowie alkyl-spectinomycin-analogen
DE2719916C2 (de) Verfahren zur Herstellung von 2,9-Dioxatricyclo[4,3,1,0↑3↑↑,↑↑7↑]decanen
DE2453649A1 (de) Verfahren zur herstellung von coformycin
DE2849666A1 (de) Verfahren zur herstellung des antibiotikums c-15003 p 4
EP0359187B1 (de) Basische Spaltungsprodukte von Elaiophylin und Elaiophylinderivaten und Verwendung derselben
DE3008649C2 (enExample)
DE3722698A1 (de) Zytostatisch wirksame anthracyclinderivate
DE2234804A1 (de) Gentamicinderivate und verfahren zur herstellung derselben
DE102004005106A1 (de) Sorbifuranone, Sorbivineton, Sorbivinetol und Derivate dieser Verbindungen, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren Verwendung
EP0030331B1 (de) Neue C-3-verzweigte Cardenolid-glykoside, ihre Herstellung und Verwendung
DE1913491B2 (de) Verfahren zur Herstellung von 4,5-Epoxy-14-beta-hydroxy-20,22-bufadienoliden sowie 4,5 -Epoxy-14 beta-hydroxy-20,22-bufadienolW-Verbindungen
DE1493253C (enExample)